黑料官网

header-logo
GettyImages-609179959-hero
headshot

John A. Charlson, MD

Associate Professor

view provider profile

Locations

  • Froedtert Hospital
  • Clinical Cancer Center - Froedtert Hospital

Specialties

  • Medical Oncology

Languages

  • English

Clinical Cancer Center - Froedtert Hospital

Education

  • MD - Doctor of Medicine

Biography

John Charlson, MD, is Associate Professor of Medicine at the 黑料官网, Division of Hematology and Oncology, specializing in sarcoma, breast cancer and solid malignancies. He graduated from the University of Iowa, College of Medicine in 1999, and then completed an internal medicine residency at the 黑料官网 Affiliated hospitals, serving as chief resident. He completed his fellowship in oncology in 2007, and is board certified in medical oncology. Dr. Charlson is the 黑料官网 PI for several breast cancer and sarcoma clinical trials.

Research Interests

Dr. Charlson’s clinical focus is on the care of patients with sarcoma and breast cancer. Additionally, his time is spent on quality improvement efforts within the Cancer Center and as an investigator on a number of chemotherapy clinical trials. His research interests are health services research and outcomes of patients treated for breast cancer and sarcoma.

Publications

  • (Monga V, Okuno S, Van Tine B, Pollack SM, Weiss M, Hirbe A, Viveiros P, Schulte B, Attia S, Siontis B, Milhem MM, Charlson JA, Robinson S, Okunowo O, Frankel P, Woo D, Yoon J, Agulnik M.) Lancet Oncol. 2026 Feb;27(2):223-232 PMID: 41554272 SCOPUS ID: 2-s2.0-105029655679 01/20/2026

  • (Fradin JJ, Charlson JA.) Cancers (Basel). 2025 Apr 12;17(8) PMID: 40282478 PMCID: PMC12026197 04/26/2025

  • (Ibrahim EH, Chaudhary L, Cheng YC, Sosa A, An D, Charlson J.) Radiol Oncol. 2025 Mar 01;59(1):79-90 PMID: 40014780 PMCID: PMC11867570 SCOPUS ID: 2-s2.0-86000078216 02/27/2025

  • (Pierro M, Charlson JA.) JCO Oncology Practice. 14 October 2025;21:529-529 SCOPUS ID: 2-s2.0-105034158663 10/14/2025

  • (Schroeder MC, Viyyuri BR, McDougall D, Phadke SD, Charlson JA, Estrada-Merly N, Chapman CG, Neuner JM.) Journal of Clinical Oncology. June 2025;43:e23347-e23347 SCOPUS ID: 2-s2.0-105030506681 06/01/2025

  • (.) Cancer Survivorship Research and Care. 04/07/2025

  • (Fradin JJ, Charlson JA.) Cancers. April 2025;17(8) SCOPUS ID: 2-s2.0-105003535352 04/01/2025

  • (D'Angelo SP, Araujo DM, Abdul Razak AR, Agulnik M, Attia S, Blay JY, Carrasco Garcia I, Charlson JA, Choy E, Demetri GD, Druta M, Forcade E, Ganjoo KN, Glod J, Keedy VL, Le Cesne A, Liebner DA, Moreno V, Pollack SM, Schuetze SM, Schwartz GK, Strauss SJ, Tap WD, Thistlethwaite F, Valverde Morales CM, Wagner MJ, Wilky BA, McAlpine C, Hudson L, Navenot JM, Wang T, Bai J, Rafail S, Wang R, Sun A, Fernandes L, Van Winkle E, Elefant E, Lunt C, Norry E, Williams D, Biswas S, Van Tine BA.) Lancet. 2024 Apr 13;403(10435):1460-1471 PMID: 38554725 PMCID: PMC11419333 SCOPUS ID: 2-s2.0-85188995845 03/31/2024

  • (Wilcox T, Kleinertz A, Seadler BD, Joyce LD, Charlson J, Linsky PL.) Rare Tumors. 2024;16:20363613241274230 PMID: 39139396 PMCID: PMC11320392 08/14/2024

  • (Aggen DH, Garcia A, Saro Suarez JM, Sauer A, Cristiani S, Brophy FE, Streets S, Norry E, Nelson AA, Kilari D, Garmezy B, Charlson JA, Zugazagoitia J, Calvo E, Moreno I, Moreno V, Hoimes CJ, Hong DS, Cervantes A.) Journal of Clinical Oncology. February 2024;42:TPS708-TPS708 SCOPUS ID: 2-s2.0-105024695982 02/01/2024

  • (Gutkin PM, King DM, Charlson J, Wooldridge A, Hackbarth D, Kelly TR, Neilson J, Johnstone C, Bedi M.) Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):S148-S149 PMID: 37784375 10/03/2023

  • (Prior PW Jr, Nasief HG, Mannem R, Charlson J, Fernando S, Bedi M.) Int J Radiat Oncol Biol Phys. 2023 Oct 01;117(2S):e708 PMID: 37786072 10/03/2023

Publications of from the

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.